3-carbamoyl-3-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-2,2-dimethylpropanoic acid
Structure Info
- Chemspace ID
- CSSB00159247553 (In-Stock Building Blocks)
- IUPAC Name
- 3-carbamoyl-3-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-2,2-dimethylpropanoic acid
- Mol formula
- C21H28N4O4
- Mol weight
- 400 Da
- Catalog Number(s)
- AA01EPHQ, AG01EPKI, AX65738, CSC159247553, M104113, ST01ER1A, TX01EQQ6
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 2.69
- Heavy atoms count
- 29
- Rotatable bond count
- 7
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.523
- Polar surface area (Å)
- 127
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 3
- Zoom the structure
- CSSB00159247553
Items Overall 10 items from 5 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 mg | 136.40 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 5 mg | 526.90 | |
Description: MAB-CHMINACA metabolite M6; CAS: 2748161-37-5 | ||||||
| Angene US | 10 days | United States To: | 98 | 1 mg | 166.50 | |
| Angene US | 10 days | United States To: | 98 | 5 mg | 640.80 | |
Description: MAB-CHMINACA metabolite M6; CAS: 2748161-37-5 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 1 mg | 148.35 | |
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 572.70 | |
Description: MAB-CHMINACA metabolite M6; CAS: 2748161-37-5 | ||||||
| AA BLOCKS | 12 days | United States To: | 98 | 1 mg | 158.40 | |
| AA BLOCKS | 12 days | United States To: | 98 | 5 mg | 609.40 | |
Description: MAB-CHMINACA metabolite M6; CAS: 2748161-37-5 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 1 mg | 115.50 | |
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 443.30 | |
Description: MAB-CHMINACA metabolite M6; CAS: 2748161-37-5 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 4-hydroxy-2-({1-[(4-hydroxycyclohexyl)methyl]-1H-indazol-3-yl}formamido)-3,3-dimethylbutanamide - CSSB00102520515](/st/structure/200/b217963d1261d4cfa99be2e91672f4a2/CC%2528C%2529%2528CO%2529C%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCC%2528O%2529CC2%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO.png)
![Chemical structure of 3-carbamoyl-3-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-2-methylpropanoic acid - CSSB00159239438](/st/structure/200/deb07801773bc576f9c2e0c5767c2d31/CC%2528C%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO%2529C%2528O%2529%253DO.png)
![Chemical structure of (2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanoic acid - CSSB00102520504](/st/structure/200/7b6eda5fc575eea27a2cea4acd0300a9/CC%2528C%2529%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12%2529C%2528O%2529%253DO.png)
![Chemical structure of (2S)-2-{[1-(cyclohexylmethyl)-1H-indazol-3-yl]formamido}-3-phenylpropanamide - CSSB00159240501](/st/structure/200/ad9aabeee8f9a6e1310819145bd833e1/NC%2528%253DO%2529%255BC%2540H%255D%2528CC1%253DCC%253DCC%253DC1%2529NC%2528%253DO%2529C1%253DNN%2528CC2CCCCC2%2529C2%253DCC%253DCC%253DC12.png)
![Chemical structure of 2-{[1-(5-hydroxypentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanamide - CSSB00159239753](/st/structure/200/d1848a550b2274a9a83d569b837374f5/CC%2528C%2529%2528C%2529C%2528NC%2528%253DO%2529C1%253DNN%2528CCCCCO%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO.png)
![Chemical structure of 4-(3-{[(1S)-1-carbamoyl-2,2-dimethylpropyl]carbamoyl}-1H-indazol-1-yl)butanoic acid - CSSB00160812649](/st/structure/200/a6af370cbfbac6eeaf61e75e7c2fae24/CC%2528C%2529%2528C%2529%255BC%2540H%255D%2528NC%2528%253DO%2529C1%253DNN%2528CCCC%2528O%2529%253DO%2529C2%253DCC%253DCC%253DC12%2529C%2528N%2529%253DO.png)
![Chemical structure of 2-{[1-(4-hydroxypentyl)-1H-indazol-3-yl]formamido}-3,3-dimethylbutanamide - CSSB00159239750](/st/structure/200/10d5e3915d02610378e7f7d30a3df6d4/CC%2528O%2529CCCN1N%253DC%2528C%2528%253DO%2529NC%2528C%2528N%2529%253DO%2529C%2528C%2529%2528C%2529C%2529C2%253DCC%253DCC%253DC12.png)
